These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 9836243)

  • 21. Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents.
    Alfredo BA; Ofir P
    Eur J Pharmacol; 2005 Jan; 508(1-3):155-8. PubMed ID: 15680266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different receptor subtypes are involved in the serotonin-induced modulation of epileptiform activity in rat frontal cortex in vitro.
    Bobula B; Zahorodna A; Bijak M
    J Physiol Pharmacol; 2001 Jun; 52(2):265-74. PubMed ID: 11453105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats.
    Haleem DJ; Khan NH
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):645-51. PubMed ID: 12787852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hypergravic fields on serotonergic neuromodulation in the rat hippocampus.
    Horrigan DJ; Fuller CA; Horowitz JM
    J Gravit Physiol; 1997 Oct; 4(3):21-30. PubMed ID: 11541865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evidence for a central antihypertensive effect of indorenate.
    Hong E; Rion R; Aceves J; Benitez-King G; Anton-Tay F
    Proc West Pharmacol Soc; 1987; 30():1-3. PubMed ID: 3476964
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of high affinity serotonin receptors in neuronal growth.
    Whitaker-Azmitia PM; Shemer AV; Caruso J; Molino L; Azmitia EC
    Ann N Y Acad Sci; 1990; 600():315-30. PubMed ID: 2252318
    [No Abstract]   [Full Text] [Related]  

  • 28. New drugs of abuse update: Foxy Methoxy.
    Muller AA
    J Emerg Nurs; 2004 Oct; 30(5):507-8. PubMed ID: 15452541
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of the discriminative stimulus properties of indorenate by 5-HT receptors.
    Miranda F; Hong E; López Cabrera M; Velázquez Martínez DN
    Proc West Pharmacol Soc; 1998; 41():59-60. PubMed ID: 9836243
    [No Abstract]   [Full Text] [Related]  

  • 30. Discriminative stimulus properties of indorenate, a serotonin agonist.
    Velázquez-Martínez DN; López Cabrera M; Sánchez H; Ramírez JI; Hong E
    J Psychiatry Neurosci; 1999 Mar; 24(2):122-30. PubMed ID: 10212554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal gradient of the discriminative stimulus properties of indorenate.
    Sánchez H; Ramírez JI; López Cabrera M; Velázquez Martínez DN
    Proc West Pharmacol Soc; 1998; 41():121-2. PubMed ID: 9836265
    [No Abstract]   [Full Text] [Related]  

  • 32. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
    Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative stimulus properties of indorenate in a conditioned taste aversion paradigm.
    Miranda F; Hong E; Velázquez-Martínez DN
    Pharmacol Biochem Behav; 2001 Mar; 68(3):427-33. PubMed ID: 11325395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors.
    Miranda F; Hong E; Sánchez H; Velázquez-Martínez DN
    Pharmacol Biochem Behav; 2003 Jan; 74(2):371-80. PubMed ID: 12479957
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.